| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.4373 | 24 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.5821 | 35 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.386 | 43 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.6761 | 47 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.3733 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.101 | 45 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.2914 | 49 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.0769 | 41 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.1427 | 23 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.5887 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.5304 | 47 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.6895 | 40 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.7043 | 31 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.142 | 49 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.0721 | 41 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.7647 | 53 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.6732 | 44 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.2774 | 52 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.8063 | 40 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.6447 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.7378 | 56 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.5648 | 43 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.1198 | 28 |